Treatment Updates in Demyelinating Disorders of CNS and Myasthenia Gravis (10/10/25)

Friday, October 10, 2025, 8:00 AM - 4:00 PM, Hybrid - Gem Theatre & Microsoft Teams, Detroit, MI


AMA PRA Category 1 Credits™ (6.50 hours), AMA PRA Non-Physician Attendance (6.50 hours)

The past few years have been very exciting in the multiple sclerosis ( MS), demyelinating disorders of central nervous system ( NMOSD, MOGAD) and myasthenia gravis ( MG) field. There have been quite a few new treatments approved lately for management of MS, NMOSD, MG. We have gathered some of the best experts in neurology, infection disease, hepatology, surgery and obstetrics to answer the most commonly encountered questions regarding the complex treatment management and monitoring of patients with MS, NMOSD, MG.

1. Demonstrate knowledge of diagnosis criteria of multiple sclerosis and demyelinating disorders of central nervous system.
2. Demonstrate knowledge of Myasthenia gravis classification and clinical assessment
3. Demonstrate knowledge of new immunomodulatory and immunosuppressive treatments of MS, NMOSD, MG and monitoring requirements of each treatment
4. Address and discuss with patients' treatment of MS, NMOSD, MG in pregnancy, postpartum/breastfeeding
5. Become familiar with plasma exchange treatment in acute presentations of MS, NMOSD, MG
6. Demonstrate familiarity with surgical treatment indication for MG
7. Demonstrate familiarity with required immunization, treatment of infections with immunosuppressive therapy for MS, NMOSD, MG

Henry Ford Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

DESIGNATION STATEMENT:

Henry Ford Health designates this live course for a maximum of 6.50 AMA PRA Category 1 Credit(s) TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

 

FACULTY/PLANNING COMMITTEE DISCLOSURE STATEMENT: 

 In compliance with the ACCME standards for Commercial Support, all individuals in a position to control/influence the content of this activity are required to disclose all financial interests of their own with any ACCME defined commercial interests for the past 24 months and/or non-FDA approved use of a drug or a device that is included in the presentation. All financial relationships have been mitigated prior to the commencement of the activity.

 

ACCESSIBILITY STATEMENT: 

Henry Ford Health provides qualified interpreters and other aids for Deaf, DeafBlind, and Hard-of-Hearing persons at no cost. To request assistance, contact the event coordinator: Nestelynn Gay at  [email protected] Please allow a minimum of 3 days to process this request.

Cancellation Policy

Please send cancellation requests to [email protected].

Henry Ford Health Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

The Henry Ford Health Office of Continuing Medical Education adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Henry Ford Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, October 10, 2025